Open AccessMetformin in gestational diabetes mellitus: predictors of poor response
Author(s) -
Inês Gante,
Luís André Godinho Melo,
Jorge Dores,
Luísa Ruas,
Maria do Céu Almeida
Publication year - 2017
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-17-0486
Subject(s) - metformin , medicine , glycemic , gestational diabetes , body mass index , pregnancy , insulin , cohort , diabetes mellitus , retrospective cohort study , obstetrics , endocrinology , gestation , genetics , biology
Metformin can be regarded as a first-line treatment in gestational diabetes mellitus (GDM) due to its safety and effectiveness. However, a proportion of women do not achieve adequate glycemic control with metformin alone. We aim to identify predictors of this poor response to metformin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom